Syntax Bio, a synthetic biology company programming the next generation of cell therapies, today announced it has received an award of up to $856,250 from Breakthrough T1D, the leading global type 1 ...
This proposal aims to enable developers to add type annotations to their JavaScript code, allowing those annotations to be checked by a type checker that is external to JavaScript. At runtime, a ...
Funding will accelerate development of manufactured pancreatic beta cells capable of restoring insulin production using Syntax’s Cellgorithm™ technology CHICAGO & NEW YORK, December 10, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback